A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Clinical trial NCT02349295 · COMPLETED

Trial details

NCT number: NCT02349295
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2014-12-31
Primary completion: 2016-09-09
Enrollment: 363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.